Degnan Chrisinsider trades

In SEC Form 4 filings, Degnan Chris is listed as Chief Financial Officer of UroGen Pharma Ltd. (URGN). In the last 90 days, Degnan Chris sold $80.8K of UroGen Pharma Ltd. (URGN) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
URGNUroGen Pharma Ltd.	Chief Financial Officer	3	Oct 9

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-09

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
URGNUroGen Pharma Ltd.	Oct 8	Oct 9	M	4,483	not reported	not reported	6,763	No	Form 4
URGNUroGen Pharma Ltd.	Oct 8	Oct 9	S	2,202	$36.69	Sale −$80,791	4,561	No	Form 4
URGNUroGen Pharma Ltd.	Oct 8	Oct 9	M · derivative	4,483	$0.00	$0	4,484	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.